MYCN is highly expressed in many cancers, including neuroblastoma (NB) (Huang and Weiss, 2013), medulloblastoma (Korshunov et al., 2012), cervical cancer (García et al., 2024), and non-small cell lung cancer (Dietzsch et al., 1994). This evidence concerns the gene MYCN and medulloblastoma.